Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Nov;128(5):1105-13.
doi: 10.1038/sj.bjp.0702834.

Proteinase activated receptor 2: Role of extracellular loop 2 for ligand-mediated activation

Affiliations

Proteinase activated receptor 2: Role of extracellular loop 2 for ligand-mediated activation

B Al-Ani et al. Br J Pharmacol. 1999 Nov.

Abstract

1. Rat proteinase-activated receptor-2 (PAR2) variants were stably expressed in rat KNRK cells: (a) wild-type (wt) - PAR2; (b) PAR2PRR, with the extracellular loop 2 (EL-2) sequence P231E232E233mutated to PRR and (c) PAR2NET, with the EL-2 sequence, PEEV changed to NETL. Cell lines were evaluated for their sensitivity (calcium signalling) towards trypsin and the receptor-activating peptides, SLIGRL-NH2, SLIGEL-NH2, trans-cinnamoyl(tc)-LIGRLO-NH2, and SFLLR-NH2. 2. SLIGEL-NH2 exhibited low potency (1 : 200 relative to SLIGRL-NH2) in wild-type PAR2. Its activity was increased 5 fold in PAR2PRR, but it was inactive in PAR2NET. 3. In PAR2PRR, the potencies of SLIGRL-NH2, tc-LIGRLO-NH2, and SFLLR-NH2 were decreased by 80 - 100 fold. But, the potency of trypsin was decreased by only 7 fold. 4. In PAR2NET, highly homologous in EL-2 with proteinase-activated receptor-1 (PAR1), the potency of the PAR1-derived peptide, SFLLR-NH2, was reduced by 100 fold compared with wt-PAR2, whereas the potency of the PAR2-derived AP, SLIGRL-NH2 was reduced 10 fold. In contrast, the potency of trypsin in PAR2NET was almost the same as in wt-PAR2. 5. We conclude that the acidic EL-2 tripeptide, PEE, in PAR2 plays an important role in governing agonist activity. 6. The data obtained with the PEEV-->NETL mutation suggested: (a) that SLIGRL-NH2 and SFLLR-NH2 interact in a distinct manner with PAR2 and (b) that SFLLR-NH2 may interact differently with PAR2 than it does with PAR1. 7 The differential reductions in the potencies of SLIGRL-NH2, compared with trypsin in the PAR2PRR and PAR2NET cell lines point to differences between the interactions of the trypsin-revealed tethered ligand and the free receptor-activating peptide with PAR2.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Sequences of PAR2 variants compared with PAR2 and PAR1 (upper panel) and their expression in KNRK cells (middle and lower panel). (Upper panel) The sequences of the extracellular loop 2 of wtPAR2 (PAR2) and the two receptor variants (PAR2PRR, PAR2NET) are compared with the extracellular loop 2 sequence of rat PAR1. The bold print of the PAR1 sequence denotes the region of high sequence homology between PAR1 and PAR2. (Middle panel) Cellular fluorescence intensity detected with the B5 anti-PAR2 antiserum was monitored by fluorescence-activated cell sorting for untransfected KNRK cells (dashed lines; same signal was observed for vector-transfected cells) or for wt-PAR2-expressing cells (solid lines). (Lower panel) The expression of receptor mRNAs for the host wild-type KNRK cells, (Wt-PAR2), PAR2PRR (PRR) and PAR2NET (NET) were determined by RT–PCR. The RT–PCR signal observed for actin was the same in all cell lines (not shown). The positions of the oligonucleotide size markers (in base-pairs) are shown on the left (lane M). The position of the expected PCR product for PAR2 (560 base-pairs) is shown on the right. Identical amounts of RNA obtained from each cell line were subjected to analysis by RT–PCR, as outlined in Methods.
Figure 2
Figure 2
Calcium signalling by wt-PAR2 (a, b), PAR2PRR (c, d) and PAR2NET (e, f). Comparative responses to SLIGRL-NH2 (SL-NH2, ○) and SLIGEL-NH2 (SE-NH2, ▪) [fluorescence (E530), reflecting increases in intracellular calcium] were monitored in fluo-3-loaded cell lines stimulated by either SLIGRL-NH2 (a, c, e) or SLIGEL-NH2 (b, d, f). The concentrations of peptide agonists were adjusted in an attempt to show comparable increases in fluorescence, relative to the signal yielded in each cell sample by 2 μM of the ionophore A23187 (▴). (a, b) wt-PAR2; (c, d) PAR2PRR; (e, f) PAR2NET. The PAR2NET cell line responded poorly to relatively high concentrations of SLIGEL-NH2 (f and Figure 5).
Figure 3
Figure 3
Concentration-effect curves for PAR-APs and trypsin in wt-PAR2 cells. The fluorescence responses relative to the signal caused in identical cell suspensions by 2 μM A23187 (E530: %A23187) were measured in replicate cell suspensions, as outlined in Methods, for increasing concentrations of the indicated PAR-APs and trypsin. Values represent the averages (±s.e.mean, bars) for measurements done with four or more replicate cell suspensions coming from two or more independently grown crops of cells. Error bars smaller than the symbols are not shown.
Figure 4
Figure 4
Concentration effect curves for PAR-APs and trypsin in PAR2PRR cells. The fluorescence responses relative to the signal caused by 2 μM A23187 (E530: %A23187) were measured for increasing concentrations of the indicated PAR-APs and trypsin, exactly as described in the legend to Figure 3.
Figure 5
Figure 5
Concentration-effect curves for PAR-APs and trypsin in PAR2-NET cells. Concentration-effect curves for the fluorescence response relative to 2 μM A23187 (E530: %A23187) were obtained for the same PAR-APs and trypsin, as outlined in the legends to Figures 3 and 4.

References

    1. AL-ANI B., SAIFEDDINE M., HOLLENBERG M.D. Detection of functional receptors for the proteinase-activated receptor-2-activating polypeptide, SLIGRL-NH2 in rat vascular and gastric smooth muscle. Can. J. Physiol. Pharmacol. 1995;73:1203–1207. - PubMed
    1. AL-ANI B., SAIFEDDINE M., KAWABATA A., RENAUX B., MOKASHI S., HOLLENBERG M.D.Proteinase activated receptor-2 (PAR2): Development of a ligand binding assay correlating with activation of PAR2 by PAR1- and PAR2-derived peptide ligands J. Pharmacol. Exp. Ther. 1999. in press - PubMed
    1. BLACKHART B.D., EMILSSON K., NGUYEN D., TENG W., MARTELLI A.J., NYSTEDT S., SUNDELIN J., SCARBOROUGH R.M. Ligand cross-reactivity within the protease-activated receptor family. J. Biol. Chem. 1996;271:16466–16471. - PubMed
    1. BÖHM S.K., KONG W., BRÖMME D., SMEEKENS S.P., ANDERSON D.C., CONNOLLY A., KAHN M., NELKEN N.A., COUGHLIN S.R., PAYAN D.G., BUNNETT N.W. Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem. J. 1996;314:1009–1016. - PMC - PubMed
    1. CHAO B.H., KALKUNTE S., MARAGANORE J.M., STONE S.R. Essential groups in synthetic agonist peptides for activation of the platelet thrombin receptor. Biochemistry. 1992;31:6175–6178. - PubMed

Publication types

MeSH terms

LinkOut - more resources